Table 1.
Demographic and health characteristics of subjects1.
| Placebo (n = 16) | Vitamin B-6 (n = 17) | |
|---|---|---|
| Age (y) | 61.0 ± 2.7 | 56.7 ± 3.6 |
| Sex (male/female) | 9/7 | 13/4 |
| Body mass index (kg/m2) | 25.1 ± 1.0 | 24.6 ± 0.8 |
| Blood pressure (mmHg) | ||
| Systolic | 130.4 ± 5.1 | 125.0 ± 3.3 |
| Diastolic | 73.6 ± 3.0 | 74.9 ± 3.0 |
| Serum albumin (g/dL) | 4.1 ± 0.1 | 4.4 ± 0.1 |
| Serum creatinine (mg/dL) | 0.8 ± 0.1 | 0.9 ± 0.1 |
| Cancer stage (n, %) | ||
| Stage I | 9 (56.3%) | 11 (64.8%) |
| Stage II | 7 (43.8%) | 6 (35.3%) |
| Histological grading (n, %) | ||
| Well differentiated (I) | 1 (6.3%) | 1 (5.9%) |
| Moderate differentiated (II) | 3 (18.8%) | 4 (23.5%) |
| Poor differentiated (III) | 12 (75%) | 12 (70.6%) |
| Smoking (n, %) | ||
| Yes | 4 (25%) | 4 (23.5%) |
| No | 12 (75%) | 13 (76.5%) |
| Drinking (n, %) | ||
| Yes | 3 (18.8%) | 2 (11.8%) |
| No | 13 (81.3%) | 15 (88.2%) |
1Values are means ± standard error of mean (SE).